Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.38 -0.02 (-5.64%)
As of: Oct 22, 2026 · 9:40 AM EDT

Citius Pharmaceuticals (CTXR) Debt Ratio (2011 - 2026)

Updated

Citius Pharmaceuticals' (CTXR) Debt Ratio was 0.05 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 475.3% from 0.01 a year earlier.

Analysis

Citius Pharmaceuticals (CTXR) Debt Ratio (2011 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Debt Ratio at Citius Pharmaceuticals was 0.01.

  • The fiscal Q3 2026 figure ranks as the highest quarterly Debt Ratio since fiscal Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,152.37 Bn 1,120.96 Bn 19.71 Bn 0.39
2 Johnson & Johnson 628.86 Bn 547.39 Bn 17.26 Bn 0.24
3 AbbVie 500.37 Bn 473.48 Bn 12.70 Bn 0.52
4 Merck 374.01 Bn 328.39 Bn 12.21 Bn 0.42
5 Novartis Ag 300.56 Bn 264.55 Bn 11.24 Bn 0.08
6 Astrazeneca 263.92 Bn 237.60 Bn 12.86 Bn 0.28
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn 0.60
8 Gilead Sciences 192.21 Bn 166.40 Bn 6.22 Bn 0.53
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn 0.31
10 Citius Pharmaceuticals 9.92 Mn -23.65 Mn 1.00 Mn 0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.01
Mar 31, 2020 0.01
Dec 31, 2019 0.01
Sep 30, 2019 0.00
Jun 30, 2019 0.01
Mar 31, 2019 0.01
Dec 31, 2018 0.01
Sep 30, 2018 0.01
Jun 30, 2018 0.01
Mar 31, 2018 0.01
Dec 31, 2017 0.01
Sep 30, 2017 0.01
API Access

Citius Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CTXR&period=max&api_key=YOUR_API_KEY